Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
An Extension Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
- Status
- RECRUITING
- Phase
- PHASE1
The Accurateness of Endoscopic Ultrasound Elastography in the Guidance of EUS-FNA in Solid Pancreatic Lesions
- Status
- UNKNOWN
- Phase
- N/A
Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Prospective Monocentric Clinical-biological Database
- Status
- RECRUITING
- Phase
- NA
Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- N/A
Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Pilot Study of BXCL701 in Patients With Pancreatic Cancer
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- N/A
Development of Biomarker for the Evaluation of Response After Neoadjuvant Therapy in Patients With Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- NA
Usefulness of Smartphone Application for Improving Nutritional Status of Pancreatic Cancer Patients
- Status
- COMPLETED
- Phase
- NA
LS301 Uptake in Tumors of Patients Undergoing Liver, Pancreas, or Gastric Surgery
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Quebec Pancreas Cancer Study
- Status
- RECRUITING
- Phase
- N/A
Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast
- Status
- AVAILABLE
- Phase
- N/A